$NXPI
NXP Semiconductors NV Stock $nxpi

$nxpi Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000141344724000072 Filed on July 23, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$3.250B	$3.127B
YoY Change	-1.49%	0.19%
Cost Of Revenue	$1.384B	$1.335B
YoY Change	-2.4%	-1.18%
Gross Profit	$1.866B	$1.792B
YoY Change	-0.8%	1.24%
Gross Profit Margin	57.42%	57.31%
Selling, General & Admin	$265.0M	$270.0M
YoY Change	-3.28%	-3.57%
% of Gross Profit	14.2%	15.07%
Research & Development	$577.0M	$594.0M
YoY Change	-2.04%	2.95%
% of Gross Profit	30.92%	33.15%
Depreciation & Amortization	$218.0M	$213.0M
YoY Change	-22.42%	-24.73%
% of Gross Profit	11.68%	11.89%
Operating Expenses	$871.0M	$892.0M
YoY Change	-7.73%	-5.31%
Operating Profit	$990.0M	$896.0M
YoY Change	5.66%	8.61%
Interest Expense	$96.00M	$97.00M
YoY Change	-11.93%	-12.61%
% of Operating Profit	9.7%	10.83%
Other Income/Expense, Net	-$82.00M	-$75.00M
YoY Change	10.81%	-8.54%
Pretax Income	$908.0M	$821.0M
YoY Change	5.21%	10.5%
Income Tax	$173.0M	$154.0M
% Of Pretax Income	19.05%	18.76%
Net Earnings	$718.0M	$658.0M
YoY Change	2.87%	6.99%
Net Earnings / Revenue	22.09%	21.04%
Basic Earnings Per Share	$2.82	$2.58
Diluted Earnings Per Share	$2.79	$2.54
COMMON SHARES
Basic Shares Outstanding	254.7M shares	255.7M shares
Diluted Shares Outstanding	257.7M shares	258.7M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.749B	$2.866B
YoY Change	-29.13%	-27.24%
Cash & Equivalents	$2.748B	$2.859B
Short-Term Investments	$1.000M	$7.000M
Other Short-Term Assets	$574.0M	$546.0M
YoY Change	37.98%	41.09%
Inventory	$2.234B	$2.148B
Prepaid Expenses
Receivables	$1.070B	$927.0M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$7.026B	$6.880B
YoY Change	-5.65%	-6.48%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.309B	$3.289B
YoY Change	4.98%	5.32%
Goodwill	$9.958B	$9.941B
YoY Change	0.08%	-0.08%
Intangibles
YoY Change
Long-Term Investments	$264.0M	$117.0M
YoY Change	156.31%	13.59%
Other Assets	$2.641B	$2.290B
YoY Change	23.64%	9.31%
Total Long-Term Assets	$16.64B	$16.32B
YoY Change	1.8%	-0.36%
TOTAL ASSETS
Total Short-Term Assets	$7.026B	$6.880B
Total Long-Term Assets	$16.64B	$16.32B
Total Assets	$23.67B	$23.20B
YoY Change	-0.53%	-2.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$899.0M	$929.0M
YoY Change	-7.03%	-7.29%
Accrued Expenses	$416.0M	$402.0M
YoY Change	-5.45%	-18.13%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change	-100.0%
Long-Term Debt Due	$499.0M	$499.0M
YoY Change	-50.05%	-50.0%
Total Short-Term Liabilities	$2.992B	$3.112B
YoY Change	-26.76%	-26.13%
LONG-TERM LIABILITIES
Long-Term Debt	$9.683B	$9.681B
YoY Change	-4.8%	-4.8%
Other Long-Term Liabilities	$1.189B	$1.003B
YoY Change	17.26%	-5.11%
Total Long-Term Liabilities	$10.93B	$10.74B
YoY Change	-2.67%	-4.72%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.992B	$3.112B
Total Long-Term Liabilities	$10.93B	$10.74B
Total Liabilities	$13.93B	$13.85B
YoY Change	-9.09%	-10.55%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.582B	-$2.036B
YoY Change	-50.99%	-44.25%
Common Stock	$14.91B	$14.79B
YoY Change	3.89%	3.78%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$9.406B	$9.018B
YoY Change
Total Liabilities & Shareholders Equity	$23.67B	$23.20B
YoY Change	-0.53%	-2.26%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	$718.0M	$658.0M
YoY Change	2.87%	6.99%
Depreciation, Depletion And Amortization	$218.0M	$213.0M
YoY Change	-22.42%	-24.73%
Cash From Operating Activities	$779.0M	$761.0M
YoY Change	3.04%	20.41%
INVESTING ACTIVITIES
Capital Expenditures	$212.0M	$240.0M
YoY Change	-15.87%	-4.38%
Acquisitions
YoY Change
Other Investing Activities	-$159.0M	$1.000M
YoY Change	5200.0%	-101.72%
Cash From Investing Activities	-$371.0M	-$239.0M
YoY Change	45.49%	-31.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-526.0M	-567.0M
YoY Change	-6.9%	186.36%
NET CHANGE
Cash From Operating Activities	779.0M	761.0M
Cash From Investing Activities	-371.0M	-239.0M
Cash From Financing Activities	-526.0M	-567.0M
Net Change In Cash	-118.0M	-45.00M
YoY Change	84.38%	-152.94%
FREE CASH FLOW
Cash From Operating Activities	$779.0M	$761.0M
Capital Expenditures	$212.0M	$240.0M
Free Cash Flow	$567.0M	$521.0M
YoY Change	12.5%	36.75%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	nxpi	Other Financial Income Expense Net OtherFinancialIncomeExpenseNet	-21000000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-156000000	usd
	us-gaap	Net Income Loss NetIncomeLoss	1313000000	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	259369000	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	197000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1712000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1909000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	261278000	shares
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	158000000	usd
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.183
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.184
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.172
	nxpi	Estimated Effective Income Tax Rate EstimatedEffectiveIncomeTaxRate	0.178
CY2024Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	400000000	usd
CY2023Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	409000000	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	927000000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	894000000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	2148000000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2134000000	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	546000000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	565000000	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	6880000000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	7864000000	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2290000000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2289000000	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5902000000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5660000000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3289000000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	972000000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1342000000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	922000000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	9941000000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	9955000000	usd
CY2024Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	16316000000	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	16489000000	usd
CY2024Q2	us-gaap	Assets Assets	23196000000	usd
CY2023Q4	us-gaap	Assets Assets	24353000000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1164000000	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1622000000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1855000000	usd
CY2023Q4	us-gaap	Debt Current DebtCurrent	1000000000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3112000000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4111000000	usd
CY2024Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	9681000000	usd
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	10175000000	usd
CY2023Q4	us-gaap	Restructuring Reserve Noncurrent RestructuringReserveNoncurrent	9000000	usd
CY2024Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	48000000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	44000000	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1003000000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1054000000	usd
CY2024Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	10739000000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	11282000000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	13851000000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	15393000000	usd
CY2024Q2	us-gaap	Minority Interest MinorityInterest	327000000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	316000000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.20
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	17329585	shares
CY2024Q2	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	3762000000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	90000000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2036000000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	9018000000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	8644000000	usd
	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	2000000	usd
	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	0	usd
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	9000000	usd
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-513000000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-606000000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1000000000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	483000000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	40000000	usd
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	56000000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	56000000	usd
CY2024Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	14730000000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	14501000000	usd
CY2024Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	19543790	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	17329585	shares
CY2024Q2	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	3762000000	usd
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	3210000000	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	30000000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	90000000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2036000000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2793000000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	9018000000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	8644000000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9345000000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23196000000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24353000000	usd
	us-gaap	Profit Loss ProfitLoss	1308000000	usd
	us-gaap	Profit Loss ProfitLoss	1327000000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	448000000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	564000000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	229000000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	201000000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2000000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1000000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3000000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	4000000	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	2000000	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	1000000	usd
	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	2000000	usd
	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	0	usd
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	9000000	usd
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-513000000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-606000000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1000000000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	521000000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	483000000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	40000000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9345000000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8960000000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24353000000	usd
	us-gaap	Profit Loss ProfitLoss	1308000000	usd
	us-gaap	Profit Loss ProfitLoss	1327000000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	564000000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	229000000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	201000000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2000000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1000000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3000000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	4000000	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	2000000	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	1000000	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-5000000	usd
	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	2000000	usd
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	9000000	usd
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-513000000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-606000000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1000000000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	521000000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	483000000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	40000000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	34000000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	613000000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1000000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2095000000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-763000000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-7000000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1003000000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	18000000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3862000000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3845000000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	34000000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	613000000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	313000000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1000000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1000000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2095000000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-763000000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-7000000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1000000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1003000000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	18000000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3862000000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3845000000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3863000000	usd
	us-gaap	Interest Paid Net InterestPaidNet	124000000	usd
	us-gaap	Interest Paid Net InterestPaidNet	140000000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	391000000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	533000000	usd
	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	3000000	usd
	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	1000000	usd
	nxpi	Written Down Value Of Assets Sold WrittenDownValueOfAssetsSold	-1000000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8960000000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	644000000	usd
CY2024Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	303000000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.014
CY2024Q1	us-gaap	Dividends Common Stock DividendsCommonStock	260000000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9150000000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-14000000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	3000000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7740000000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	22000000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	33000000	usd
CY2023Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	7000000	usd
CY2023Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.014
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	34000000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	613000000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	313000000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1000000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2095000000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-763000000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-7000000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1000000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1003000000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	18000000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3862000000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3845000000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2859000000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3863000000	usd
	us-gaap	Interest Paid Net InterestPaidNet	124000000	usd
	us-gaap	Interest Paid Net InterestPaidNet	140000000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	391000000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	533000000	usd
	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	3000000	usd
	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	1000000	usd
	nxpi	Written Down Value Of Assets Sold WrittenDownValueOfAssetsSold	-1000000	usd
	nxpi	Written Down Value Of Assets Sold WrittenDownValueOfAssetsSold	0	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	166000000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	165000000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8960000000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	644000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-46000000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	118000000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	37000000	usd
CY2024Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	303000000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.014
CY2024Q1	us-gaap	Dividends Common Stock DividendsCommonStock	260000000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9150000000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	664000000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-14000000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	111000000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	3000000	usd
CY2024Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	310000000	usd
CY2024Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.014
CY2024Q2	us-gaap	Dividends Common Stock DividendsCommonStock	259000000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9345000000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7740000000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	623000000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	33000000	usd
CY2023Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	7000000	usd
CY2023Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.014
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-11000000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	99000000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	1000000	usd
CY2023Q3	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	302000000	usd
CY2023Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.014
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2859000000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3863000000	usd
	us-gaap	Interest Paid Net InterestPaidNet	124000000	usd
	us-gaap	Interest Paid Net InterestPaidNet	140000000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	391000000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	533000000	usd
	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	3000000	usd
	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	1000000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	166000000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	165000000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8960000000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	644000000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	118000000	usd
CY2024Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	303000000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.014
CY2024Q1	us-gaap	Dividends Common Stock DividendsCommonStock	260000000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9150000000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	664000000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-14000000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	3000000	usd
CY2024Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	310000000	usd
CY2024Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.014
CY2024Q2	us-gaap	Dividends Common Stock DividendsCommonStock	259000000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9345000000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7740000000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	623000000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	22000000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	101000000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	33000000	usd
CY2023Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	7000000	usd
CY2023Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.014
CY2023Q2	us-gaap	Dividends Common Stock DividendsCommonStock	264000000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8248000000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	704000000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-11000000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	99000000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	1000000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9345000000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	623000000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	22000000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	101000000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	33000000	usd
CY2023Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	7000000	usd
CY2023Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.014
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8248000000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	704000000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-11000000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	99000000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	1000000	usd
CY2023Q3	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	302000000	usd
CY2023Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.014
CY2023Q3	us-gaap	Dividends Common Stock DividendsCommonStock	262000000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8477000000	usd
	us-gaap	Number Of Businesses Acquired NumberOfBusinessesAcquired	0	business
	us-gaap	Number Of Businesses Acquired NumberOfBusinessesAcquired	0	business
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8477000000	usd
	us-gaap	Number Of Businesses Acquired NumberOfBusinessesAcquired	0	business
	us-gaap	Number Of Businesses Acquired NumberOfBusinessesAcquired	0	business
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3127000000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3299000000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6253000000	usd
	us-gaap	Depreciation Depreciation	291000000	usd
	us-gaap	Depreciation Depreciation	322000000	usd
CY2024Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	213000000	usd
CY2023Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	281000000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	448000000	usd
	us-gaap	Number Of Businesses Acquired NumberOfBusinessesAcquired	0	business
	us-gaap	Number Of Businesses Acquired NumberOfBusinessesAcquired	0	business
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3127000000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3299000000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6420000000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	448000000	usd
CY2024Q2	us-gaap	Depreciation Depreciation	146000000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	162000000	usd
	us-gaap	Depreciation Depreciation	291000000	usd
CY2024Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	213000000	usd
CY2023Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	281000000	usd
	us-gaap	Number Of Businesses Acquired NumberOfBusinessesAcquired	0	business
	us-gaap	Number Of Businesses Acquired NumberOfBusinessesAcquired	0	business
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3127000000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3299000000	usd
CY2024Q2	us-gaap	Depreciation Depreciation	146000000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	162000000	usd
	us-gaap	Depreciation Depreciation	291000000	usd
CY2024Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	213000000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	448000000	usd
CY2023Q3	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	43000000	usd
	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	89000000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	109000000	usd
	nxpi	Other Financial Income Expense Net OtherFinancialIncomeExpenseNet	-32000000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-74000000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-145000000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	664000000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	704000000	usd
	us-gaap	Profit Loss ProfitLoss	1308000000	usd
CY2024Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	6000000	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	6000000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	11000000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	14000000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	698000000	usd
	us-gaap	Net Income Loss NetIncomeLoss	1297000000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	255478000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	259160000	shares
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6253000000	usd
CY2024Q2	us-gaap	Depreciation Depreciation	146000000	usd
	us-gaap	Depreciation Depreciation	291000000	usd
CY2024Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	213000000	usd
CY2023Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	281000000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	448000000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	564000000	usd
CY2024Q2	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	39000000	usd
	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	89000000	usd
CY2024Q2	us-gaap	Interest Expense InterestExpense	97000000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	109000000	usd
	us-gaap	Interest Expense InterestExpense	220000000	usd
CY2024Q2	nxpi	Other Financial Income Expense Net OtherFinancialIncomeExpenseNet	-17000000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-75000000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-74000000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-145000000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	664000000	usd
	us-gaap	Profit Loss ProfitLoss	1308000000	usd
CY2024Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	6000000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	11000000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	698000000	usd
	us-gaap	Net Income Loss NetIncomeLoss	1297000000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	255478000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	259160000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	256023000	shares
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	157000	shares
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3097000	shares
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1954000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2775000	shares
CY2024Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	3254000	shares
CY2023Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2143000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2940000	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	258732000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	261303000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	258963000	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5.06
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3862000000	usd
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.54
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.67
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5.01
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2859000000	usd
CY2024Q2	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	39000000	usd
CY2023Q3	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	43000000	usd
	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	89000000	usd
CY2024Q2	us-gaap	Interest Expense InterestExpense	97000000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	109000000	usd
	us-gaap	Interest Expense InterestExpense	202000000	usd
CY2024Q2	nxpi	Other Financial Income Expense Net OtherFinancialIncomeExpenseNet	-17000000	usd
CY2023Q3	nxpi	Other Financial Income Expense Net OtherFinancialIncomeExpenseNet	-8000000	usd
	nxpi	Other Financial Income Expense Net OtherFinancialIncomeExpenseNet	-32000000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-75000000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-74000000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-145000000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	664000000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	704000000	usd
	us-gaap	Profit Loss ProfitLoss	1308000000	usd
CY2024Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	6000000	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	6000000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	11000000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	658000000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	698000000	usd
	us-gaap	Net Income Loss NetIncomeLoss	1297000000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	259160000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	256023000	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	165000	shares
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3097000	shares
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1954000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2775000	shares
CY2024Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	3254000	shares
CY2023Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2143000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2940000	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	258732000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	261303000	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5.07
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.54
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2859000000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3862000000	usd
CY2024Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	103000000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	113000000	usd
CY2024Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1568000000	usd
CY2024Q2	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	39000000	usd
CY2023Q3	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	43000000	usd
	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	89000000	usd
	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	85000000	usd
CY2024Q2	us-gaap	Interest Expense InterestExpense	97000000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	109000000	usd
	us-gaap	Interest Expense InterestExpense	202000000	usd
CY2023Q3	nxpi	Other Financial Income Expense Net OtherFinancialIncomeExpenseNet	-8000000	usd
	nxpi	Other Financial Income Expense Net OtherFinancialIncomeExpenseNet	-32000000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-74000000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-145000000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	704000000	usd
	us-gaap	Profit Loss ProfitLoss	1308000000	usd
	us-gaap	Profit Loss ProfitLoss	1327000000	usd
CY2024Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	6000000	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	6000000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	11000000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	658000000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	698000000	usd
	us-gaap	Net Income Loss NetIncomeLoss	1297000000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	255478000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	259160000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	256023000	shares
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	189000	shares
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3097000	shares
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1954000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2775000	shares
CY2024Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	3254000	shares
CY2023Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2143000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2940000	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	258732000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	261303000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	258963000	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.58
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.69
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5.07
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.54
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.67
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5.01
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3862000000	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	256023000	shares
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	157000	shares
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	189000	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	165000	shares
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3097000	shares
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1954000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2775000	shares
CY2024Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	3254000	shares
CY2023Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2143000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2940000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	261303000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	258963000	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5.07
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.54
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.67
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5.03
CY2024Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	103000000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	113000000	usd
CY2024Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1568000000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1633000000	usd
CY2024Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	477000000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	388000000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	2148000000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2134000000	usd
CY2024Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	185000000	usd
CY2024Q2	us-gaap	Marketable Securities MarketableSecurities	7000000	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	12000000	usd
CY2024Q2	us-gaap	Other Investments OtherInvestments	66000000	usd
CY2023Q4	us-gaap	Other Investments OtherInvestments	55000000	usd
CY2024Q2	us-gaap	Equity Method Investments EquityMethodInvestments	117000000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	101000000	usd
CY2024Q2	us-gaap	Investments Investments	190000000	usd
CY2023Q4	us-gaap	Investments Investments	168000000	usd
CY2024Q2	us-gaap	Equity Method Investments EquityMethodInvestments	117000000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	101000000	usd
CY2024Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	103000000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	113000000	usd
CY2024Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1568000000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1633000000	usd
CY2024Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	477000000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	388000000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	2148000000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2134000000	usd
CY2024Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	185000000	usd
CY2024Q2	us-gaap	Marketable Securities MarketableSecurities	7000000	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	12000000	usd
CY2024Q2	us-gaap	Other Investments OtherInvestments	66000000	usd
CY2024Q2	us-gaap	Equity Method Investments EquityMethodInvestments	117000000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	101000000	usd
CY2024Q2	us-gaap	Investments Investments	190000000	usd
CY2023Q4	us-gaap	Investments Investments	168000000	usd
CY2024Q2	us-gaap	Equity Method Investments EquityMethodInvestments	117000000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	101000000	usd
CY2024Q2	nxpi	Income Loss From Equity Method Investments Before Extraordinary Items IncomeLossFromEquityMethodInvestmentsBeforeExtraordinaryItems	-3000000	usd
	nxpi	Income Loss From Equity Method Investments Before Extraordinary Items IncomeLossFromEquityMethodInvestmentsBeforeExtraordinaryItems	-5000000	usd
	nxpi	Income Loss From Equity Method Investments Before Extraordinary Items IncomeLossFromEquityMethodInvestmentsBeforeExtraordinaryItems	-3000000	usd
CY2024Q2	nxpi	Extraordinary Income Loss From Equity Method Investments ExtraordinaryIncomeLossFromEquityMethodInvestments	0	usd
CY2023Q3	nxpi	Extraordinary Income Loss From Equity Method Investments ExtraordinaryIncomeLossFromEquityMethodInvestments	0	usd
	nxpi	Extraordinary Income Loss From Equity Method Investments ExtraordinaryIncomeLossFromEquityMethodInvestments	1000000	usd
	nxpi	Extraordinary Income Loss From Equity Method Investments ExtraordinaryIncomeLossFromEquityMethodInvestments	0	usd
CY2024Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3000000	usd
CY2023Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1000000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-4000000	usd
CY2024Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	103000000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	113000000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1633000000	usd
CY2024Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	477000000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	388000000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	2148000000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2134000000	usd
CY2024Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	185000000	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	189000000	usd
CY2024Q2	us-gaap	Marketable Securities MarketableSecurities	7000000	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	12000000	usd
CY2024Q2	us-gaap	Other Investments OtherInvestments	66000000	usd
CY2023Q4	us-gaap	Other Investments OtherInvestments	55000000	usd
CY2024Q2	us-gaap	Equity Method Investments EquityMethodInvestments	117000000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	101000000	usd
CY2024Q2	us-gaap	Investments Investments	190000000	usd
CY2023Q4	us-gaap	Investments Investments	168000000	usd
CY2024Q2	us-gaap	Equity Method Investments EquityMethodInvestments	117000000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	101000000	usd
CY2024Q2	nxpi	Income Loss From Equity Method Investments Before Extraordinary Items IncomeLossFromEquityMethodInvestmentsBeforeExtraordinaryItems	-3000000	usd
CY2023Q3	nxpi	Income Loss From Equity Method Investments Before Extraordinary Items IncomeLossFromEquityMethodInvestmentsBeforeExtraordinaryItems	-1000000	usd
	nxpi	Income Loss From Equity Method Investments Before Extraordinary Items IncomeLossFromEquityMethodInvestmentsBeforeExtraordinaryItems	-5000000	usd
CY2024Q2	nxpi	Extraordinary Income Loss From Equity Method Investments ExtraordinaryIncomeLossFromEquityMethodInvestments	0	usd
CY2023Q3	nxpi	Extraordinary Income Loss From Equity Method Investments ExtraordinaryIncomeLossFromEquityMethodInvestments	0	usd
	nxpi	Extraordinary Income Loss From Equity Method Investments ExtraordinaryIncomeLossFromEquityMethodInvestments	1000000	usd
	nxpi	Extraordinary Income Loss From Equity Method Investments ExtraordinaryIncomeLossFromEquityMethodInvestments	0	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1633000000	usd
CY2024Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	477000000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	388000000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	2148000000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2134000000	usd
CY2024Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	185000000	usd
CY2024Q2	us-gaap	Marketable Securities MarketableSecurities	7000000	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	12000000	usd
CY2024Q2	us-gaap	Other Investments OtherInvestments	66000000	usd
CY2023Q4	us-gaap	Other Investments OtherInvestments	55000000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	101000000	usd
CY2024Q2	us-gaap	Investments Investments	190000000	usd
CY2023Q4	us-gaap	Investments Investments	168000000	usd
CY2024Q2	us-gaap	Equity Method Investments EquityMethodInvestments	117000000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	101000000	usd
CY2023Q3	nxpi	Income Loss From Equity Method Investments Before Extraordinary Items IncomeLossFromEquityMethodInvestmentsBeforeExtraordinaryItems	-1000000	usd
	nxpi	Income Loss From Equity Method Investments Before Extraordinary Items IncomeLossFromEquityMethodInvestmentsBeforeExtraordinaryItems	-5000000	usd
	nxpi	Income Loss From Equity Method Investments Before Extraordinary Items IncomeLossFromEquityMethodInvestmentsBeforeExtraordinaryItems	-3000000	usd
CY2024Q2	nxpi	Extraordinary Income Loss From Equity Method Investments ExtraordinaryIncomeLossFromEquityMethodInvestments	0	usd
CY2023Q3	nxpi	Extraordinary Income Loss From Equity Method Investments ExtraordinaryIncomeLossFromEquityMethodInvestments	0	usd
	nxpi	Extraordinary Income Loss From Equity Method Investments ExtraordinaryIncomeLossFromEquityMethodInvestments	1000000	usd
	nxpi	Extraordinary Income Loss From Equity Method Investments ExtraordinaryIncomeLossFromEquityMethodInvestments	0	usd
CY2024Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3000000	usd
CY2023Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1000000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-4000000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3000000	usd
CY2024Q2	nxpi	Income Loss From Equity Method Investments Before Extraordinary Items IncomeLossFromEquityMethodInvestmentsBeforeExtraordinaryItems	-3000000	usd
	nxpi	Income Loss From Equity Method Investments Before Extraordinary Items IncomeLossFromEquityMethodInvestmentsBeforeExtraordinaryItems	-5000000	usd
CY2024Q2	nxpi	Extraordinary Income Loss From Equity Method Investments ExtraordinaryIncomeLossFromEquityMethodInvestments	0	usd
CY2023Q3	nxpi	Extraordinary Income Loss From Equity Method Investments ExtraordinaryIncomeLossFromEquityMethodInvestments	0	usd
	nxpi	Extraordinary Income Loss From Equity Method Investments ExtraordinaryIncomeLossFromEquityMethodInvestments	1000000	usd
	nxpi	Extraordinary Income Loss From Equity Method Investments ExtraordinaryIncomeLossFromEquityMethodInvestments	0	usd
CY2024Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3000000	usd
CY2023Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1000000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-4000000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3000000	usd
CY2024Q2	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	402000000	usd
CY2023Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	500000000	usd
CY2024Q2	us-gaap	Customer Funds CustomerFunds	307000000	usd
CY2023Q4	us-gaap	Customer Funds CustomerFunds	280000000	usd
CY2024Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	122000000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	170000000	usd
CY2024Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	259000000	usd
CY2023Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	261000000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	532000000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	644000000	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1622000000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1855000000	usd
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	-72000000	usd
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	-9000000	usd
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-3000000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-60000000	usd
CY2024Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3000000	usd
CY2023Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1000000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-4000000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3000000	usd
CY2024Q2	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	402000000	usd
CY2023Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	500000000	usd
CY2024Q2	us-gaap	Customer Funds CustomerFunds	307000000	usd
CY2023Q4	us-gaap	Customer Funds CustomerFunds	280000000	usd
CY2024Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	122000000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	170000000	usd
CY2024Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	259000000	usd
CY2023Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	261000000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	532000000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	644000000	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1622000000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1855000000	usd
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	-72000000	usd
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	-9000000	usd
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-3000000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-60000000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.014
CY2024Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	260000000	usd
CY2023Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.014
CY2023Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	263000000	usd
CY2024Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.014
CY2024Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	259000000	usd
CY2023Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.014
CY2024Q2	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	402000000	usd
CY2023Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	500000000	usd
CY2024Q2	us-gaap	Customer Funds CustomerFunds	307000000	usd
CY2023Q4	us-gaap	Customer Funds CustomerFunds	280000000	usd
CY2024Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	122000000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	170000000	usd
CY2024Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	259000000	usd
CY2023Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	261000000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	532000000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	644000000	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1622000000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1855000000	usd
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	-72000000	usd
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	-9000000	usd
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-3000000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-60000000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.014
CY2023Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.014
CY2024Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	259000000	usd
CY2023Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.014
CY2024Q2	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	402000000	usd
CY2023Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	500000000	usd
CY2024Q2	us-gaap	Customer Funds CustomerFunds	307000000	usd
CY2023Q4	us-gaap	Customer Funds CustomerFunds	280000000	usd
CY2024Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	122000000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	170000000	usd
CY2024Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	259000000	usd
CY2023Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	261000000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	532000000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	644000000	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1622000000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1855000000	usd
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	-72000000	usd
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	-9000000	usd
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-3000000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-60000000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.014
CY2023Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.014
CY2024Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.014
CY2024Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	259000000	usd
CY2023Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.014
CY2023Q3	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	263000000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.014
CY2023Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	263000000	usd
CY2024Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.014
CY2024Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	259000000	usd
CY2023Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.014
CY2023Q4	us-gaap	Restructuring Reserve RestructuringReserve	101000000	usd
	us-gaap	Restructuring Charges RestructuringCharges	18000000	usd
	us-gaap	Payments For Restructuring PaymentsForRestructuring	45000000	usd
	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	-4000000	usd
	us-gaap	Restructuring Reserve Translation And Other Adjustment RestructuringReserveTranslationAndOtherAdjustment	-1000000	usd
CY2024Q2	us-gaap	Restructuring Reserve RestructuringReserve	69000000	usd
CY2024Q2	us-gaap	Restructuring Reserve RestructuringReserve	69000000	usd
CY2024Q2	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	62000000	usd
CY2024Q2	us-gaap	Restructuring Reserve Noncurrent RestructuringReserveNoncurrent	7000000	usd
	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	-4000000	usd
	us-gaap	Restructuring Charges RestructuringCharges	21000000	usd
	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	-3000000	usd
CY2024Q2	nxpi	Restructuring Charges Less Restructuring Reserve Accrual Adjustment RestructuringChargesLessRestructuringReserveAccrualAdjustment	6000000	usd
CY2023Q3	nxpi	Restructuring Charges Less Restructuring Reserve Accrual Adjustment RestructuringChargesLessRestructuringReserveAccrualAdjustment	0	usd
	nxpi	Restructuring Charges Less Restructuring Reserve Accrual Adjustment RestructuringChargesLessRestructuringReserveAccrualAdjustment	13000000	usd
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.258
CY2024Q2	nxpi	Income Tax Reconciliation Income Tax Expense Beneft At Estimated Annual Effective Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBeneftAtEstimatedAnnualEffectiveIncomeTaxRate	-147000000	usd
CY2023Q3	nxpi	Income Tax Reconciliation Income Tax Expense Beneft At Estimated Annual Effective Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBeneftAtEstimatedAnnualEffectiveIncomeTaxRate	-147000000	usd
CY2024Q2	nxpi	Income Tax Reconciliation Discrete Tax Items IncomeTaxReconciliationDiscreteTaxItems	-7000000	usd
CY2023Q3	nxpi	Income Tax Reconciliation Discrete Tax Items IncomeTaxReconciliationDiscreteTaxItems	-11000000	usd
	nxpi	Income Tax Reconciliation Discrete Tax Items IncomeTaxReconciliationDiscreteTaxItems	-9000000	usd
	nxpi	Income Tax Reconciliation Discrete Tax Items IncomeTaxReconciliationDiscreteTaxItems	-3000000	usd
CY2023Q4	us-gaap	Restructuring Reserve RestructuringReserve	101000000	usd
	us-gaap	Restructuring Charges RestructuringCharges	18000000	usd
	us-gaap	Payments For Restructuring PaymentsForRestructuring	45000000	usd
	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	-4000000	usd
	us-gaap	Restructuring Reserve Translation And Other Adjustment RestructuringReserveTranslationAndOtherAdjustment	-1000000	usd
CY2024Q2	us-gaap	Restructuring Reserve RestructuringReserve	69000000	usd
CY2024Q2	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	62000000	usd
CY2024Q2	us-gaap	Restructuring Reserve Noncurrent RestructuringReserveNoncurrent	7000000	usd
	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	-4000000	usd
	us-gaap	Restructuring Charges RestructuringCharges	21000000	usd
	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	-3000000	usd
CY2024Q2	nxpi	Restructuring Charges Less Restructuring Reserve Accrual Adjustment RestructuringChargesLessRestructuringReserveAccrualAdjustment	6000000	usd
CY2023Q3	nxpi	Restructuring Charges Less Restructuring Reserve Accrual Adjustment RestructuringChargesLessRestructuringReserveAccrualAdjustment	0	usd
	nxpi	Restructuring Charges Less Restructuring Reserve Accrual Adjustment RestructuringChargesLessRestructuringReserveAccrualAdjustment	13000000	usd
	nxpi	Restructuring Charges Less Restructuring Reserve Accrual Adjustment RestructuringChargesLessRestructuringReserveAccrualAdjustment	18000000	usd
	nxpi	Estimated Effective Income Tax Rate EstimatedEffectiveIncomeTaxRate	0.178
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.258
CY2024Q2	nxpi	Income Tax Reconciliation Income Tax Expense Beneft At Estimated Annual Effective Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBeneftAtEstimatedAnnualEffectiveIncomeTaxRate	-147000000	usd
CY2023Q3	nxpi	Income Tax Reconciliation Income Tax Expense Beneft At Estimated Annual Effective Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBeneftAtEstimatedAnnualEffectiveIncomeTaxRate	-147000000	usd
	nxpi	Income Tax Reconciliation Income Tax Expense Beneft At Estimated Annual Effective Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBeneftAtEstimatedAnnualEffectiveIncomeTaxRate	-286000000	usd
	nxpi	Income Tax Reconciliation Income Tax Expense Beneft At Estimated Annual Effective Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBeneftAtEstimatedAnnualEffectiveIncomeTaxRate	-273000000	usd
CY2023Q3	nxpi	Income Tax Reconciliation Discrete Tax Items IncomeTaxReconciliationDiscreteTaxItems	-11000000	usd
	nxpi	Income Tax Reconciliation Discrete Tax Items IncomeTaxReconciliationDiscreteTaxItems	-9000000	usd
	nxpi	Income Tax Reconciliation Discrete Tax Items IncomeTaxReconciliationDiscreteTaxItems	-3000000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	154000000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	295000000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	276000000	usd
CY2024Q2	nxpi	Income Tax Reconciliation Discrete Tax Items IncomeTaxReconciliationDiscreteTaxItems	-7000000	usd
CY2024Q2	nxpi	Income Tax Reconciliation Recapture Tax Effect IncomeTaxReconciliationRecaptureTaxEffect	1000000	usd
CY2024Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.188
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.184
CY2024Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.188
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.172
CY2023Q4	us-gaap	Restructuring Reserve RestructuringReserve	101000000	usd
	us-gaap	Restructuring Charges RestructuringCharges	18000000	usd
	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	-4000000	usd
	us-gaap	Restructuring Reserve Translation And Other Adjustment RestructuringReserveTranslationAndOtherAdjustment	-1000000	usd
CY2024Q2	us-gaap	Restructuring Reserve RestructuringReserve	69000000	usd
CY2024Q2	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	62000000	usd
	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	-4000000	usd
	us-gaap	Restructuring Charges RestructuringCharges	21000000	usd
CY2024Q2	nxpi	Restructuring Charges Less Restructuring Reserve Accrual Adjustment RestructuringChargesLessRestructuringReserveAccrualAdjustment	6000000	usd
	nxpi	Restructuring Charges Less Restructuring Reserve Accrual Adjustment RestructuringChargesLessRestructuringReserveAccrualAdjustment	13000000	usd
CY2024Q2	nxpi	Income Tax Reconciliation Income Tax Expense Beneft At Estimated Annual Effective Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBeneftAtEstimatedAnnualEffectiveIncomeTaxRate	-147000000	usd
CY2023Q3	nxpi	Income Tax Reconciliation Income Tax Expense Beneft At Estimated Annual Effective Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBeneftAtEstimatedAnnualEffectiveIncomeTaxRate	-147000000	usd
	nxpi	Income Tax Reconciliation Income Tax Expense Beneft At Estimated Annual Effective Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBeneftAtEstimatedAnnualEffectiveIncomeTaxRate	-286000000	usd
	nxpi	Income Tax Reconciliation Income Tax Expense Beneft At Estimated Annual Effective Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBeneftAtEstimatedAnnualEffectiveIncomeTaxRate	-273000000	usd
CY2024Q2	nxpi	Income Tax Reconciliation Discrete Tax Items IncomeTaxReconciliationDiscreteTaxItems	-7000000	usd
	nxpi	Income Tax Reconciliation Discrete Tax Items IncomeTaxReconciliationDiscreteTaxItems	-9000000	usd
	nxpi	Income Tax Reconciliation Discrete Tax Items IncomeTaxReconciliationDiscreteTaxItems	-3000000	usd
CY2024Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.188
CY2024Q2	nxpi	Income Tax Reconciliation Discrete Tax Items IncomeTaxReconciliationDiscreteTaxItems	-7000000	usd
CY2024Q2	nxpi	Income Tax Reconciliation Recapture Tax Effect IncomeTaxReconciliationRecaptureTaxEffect	1000000	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.184
	nxpi	Income Tax Reconciliation Discrete Tax Items IncomeTaxReconciliationDiscreteTaxItems	-9000000	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.172
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1768000000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	972000000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2264000000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1342000000	usd
CY2023Q4	us-gaap	Restructuring Reserve RestructuringReserve	101000000	usd
	us-gaap	Restructuring Charges RestructuringCharges	18000000	usd
	us-gaap	Payments For Restructuring PaymentsForRestructuring	45000000	usd
	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	-4000000	usd
	us-gaap	Restructuring Reserve Translation And Other Adjustment RestructuringReserveTranslationAndOtherAdjustment	-1000000	usd
CY2024Q2	us-gaap	Restructuring Reserve RestructuringReserve	69000000	usd
CY2024Q2	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	62000000	usd
CY2024Q2	us-gaap	Restructuring Reserve Noncurrent RestructuringReserveNoncurrent	7000000	usd
	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	-4000000	usd
	us-gaap	Restructuring Charges RestructuringCharges	21000000	usd
	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	-3000000	usd
CY2024Q2	nxpi	Restructuring Charges Less Restructuring Reserve Accrual Adjustment RestructuringChargesLessRestructuringReserveAccrualAdjustment	6000000	usd
	nxpi	Restructuring Charges Less Restructuring Reserve Accrual Adjustment RestructuringChargesLessRestructuringReserveAccrualAdjustment	18000000	usd
	nxpi	Estimated Effective Income Tax Rate EstimatedEffectiveIncomeTaxRate	0.178
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.258
CY2024Q2	nxpi	Income Tax Reconciliation Income Tax Expense Beneft At Estimated Annual Effective Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBeneftAtEstimatedAnnualEffectiveIncomeTaxRate	-147000000	usd
CY2023Q3	nxpi	Income Tax Reconciliation Income Tax Expense Beneft At Estimated Annual Effective Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBeneftAtEstimatedAnnualEffectiveIncomeTaxRate	-147000000	usd
	nxpi	Income Tax Reconciliation Income Tax Expense Beneft At Estimated Annual Effective Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBeneftAtEstimatedAnnualEffectiveIncomeTaxRate	-286000000	usd
	nxpi	Income Tax Reconciliation Income Tax Expense Beneft At Estimated Annual Effective Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBeneftAtEstimatedAnnualEffectiveIncomeTaxRate	-273000000	usd
CY2024Q2	nxpi	Income Tax Reconciliation Discrete Tax Items IncomeTaxReconciliationDiscreteTaxItems	-7000000	usd
CY2023Q3	nxpi	Income Tax Reconciliation Discrete Tax Items IncomeTaxReconciliationDiscreteTaxItems	-11000000	usd
	nxpi	Income Tax Reconciliation Discrete Tax Items IncomeTaxReconciliationDiscreteTaxItems	-3000000	usd
CY2024Q2	nxpi	Income Tax Reconciliation Recapture Tax Effect IncomeTaxReconciliationRecaptureTaxEffect	1000000	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.184
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.184
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.172
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1768000000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	972000000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2264000000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1342000000	usd
CY2024Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.188
CY2024Q2	nxpi	Income Tax Reconciliation Discrete Tax Items IncomeTaxReconciliationDiscreteTaxItems	-7000000	usd
CY2024Q2	nxpi	Income Tax Reconciliation Recapture Tax Effect IncomeTaxReconciliationRecaptureTaxEffect	1000000	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.184
	nxpi	Income Tax Reconciliation Discrete Tax Items IncomeTaxReconciliationDiscreteTaxItems	-9000000	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.172
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1768000000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	972000000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2264000000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1342000000	usd
	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P5Y
CY2023	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P4Y
CY2024Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	10250000000	usd
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	11250000000	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	70000000	usd
CY2024Q2	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	10180000000	usd
CY2023Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	11175000000	usd
CY2024Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	499000000	usd
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	1000000000	usd
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	10175000000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1768000000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	972000000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2264000000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1342000000	usd
	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P5Y
CY2023	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P4Y
CY2024Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	10250000000	usd
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	11250000000	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	70000000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	75000000	usd
CY2024Q2	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	10180000000	usd
CY2023Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	11175000000	usd
CY2024Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	499000000	usd
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	1000000000	usd
CY2024Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	9681000000	usd
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	10175000000	usd
	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P5Y
CY2023	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P4Y
CY2024Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	10250000000	usd
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	11250000000	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	70000000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	75000000	usd
CY2024Q2	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	10180000000	usd
CY2023Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	11175000000	usd
CY2024Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	499000000	usd
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	1000000000	usd
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	10175000000	usd
CY2024Q2	us-gaap	Purchase Obligation PurchaseObligation	3899000000	usd
	nxpi	Number Of Birth Defect Individuals NumberOfBirthDefectIndividuals	21	individual
CY2024Q2	us-gaap	Liabilities Subject To Compromise Provision For Expected And Allowed Claims LiabilitiesSubjectToCompromiseProvisionForExpectedAndAllowedClaims	95000000	usd
	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P5Y
CY2023	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P4Y
CY2024Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	10250000000	usd
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	11250000000	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	70000000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	75000000	usd
CY2024Q2	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	10180000000	usd
CY2023Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	11175000000	usd
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	1000000000	usd
CY2024Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	9681000000	usd
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	10175000000	usd
CY2024Q2	us-gaap	Purchase Obligation PurchaseObligation	3899000000	usd
	nxpi	Number Of Birth Defect Individuals NumberOfBirthDefectIndividuals	21	individual
CY2024Q2	us-gaap	Purchase Obligation PurchaseObligation	3899000000	usd
	nxpi	Number Of Birth Defect Individuals NumberOfBirthDefectIndividuals	21	individual
CY2024Q2	us-gaap	Liabilities Subject To Compromise Provision For Expected And Allowed Claims LiabilitiesSubjectToCompromiseProvisionForExpectedAndAllowedClaims	95000000	usd
CY2023Q4	us-gaap	Liabilities Subject To Compromise Provision For Expected And Allowed Claims LiabilitiesSubjectToCompromiseProvisionForExpectedAndAllowedClaims	112000000	usd
CY2024Q2	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	67000000	usd
CY2023Q4	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	67000000	usd
CY2024Q2	nxpi	Insurance Reimbursement Of Claims Potential Maximum Exposure InsuranceReimbursementOfClaimsPotentialMaximumExposure	70000000	usd
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	us-gaap	Purchase Obligation PurchaseObligation	3899000000	usd
	nxpi	Number Of Birth Defect Individuals NumberOfBirthDefectIndividuals	21	individual
CY2024Q2	us-gaap	Liabilities Subject To Compromise Provision For Expected And Allowed Claims LiabilitiesSubjectToCompromiseProvisionForExpectedAndAllowedClaims	95000000	usd
CY2023Q4	us-gaap	Liabilities Subject To Compromise Provision For Expected And Allowed Claims LiabilitiesSubjectToCompromiseProvisionForExpectedAndAllowedClaims	112000000	usd
CY2024Q2	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	67000000	usd
CY2023Q4	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	67000000	usd
CY2024Q2	nxpi	Insurance Reimbursement Of Claims Potential Maximum Exposure InsuranceReimbursementOfClaimsPotentialMaximumExposure	70000000	usd
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	us-gaap	Liabilities Subject To Compromise Provision For Expected And Allowed Claims LiabilitiesSubjectToCompromiseProvisionForExpectedAndAllowedClaims	95000000	usd
CY2023Q4	us-gaap	Liabilities Subject To Compromise Provision For Expected And Allowed Claims LiabilitiesSubjectToCompromiseProvisionForExpectedAndAllowedClaims	112000000	usd
CY2024Q2	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	67000000	usd
CY2023Q4	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	67000000	usd
CY2024Q2	nxpi	Insurance Reimbursement Of Claims Potential Maximum Exposure InsuranceReimbursementOfClaimsPotentialMaximumExposure	70000000	usd
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	us-gaap	Liabilities Subject To Compromise Provision For Expected And Allowed Claims LiabilitiesSubjectToCompromiseProvisionForExpectedAndAllowedClaims	112000000	usd
CY2024Q2	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	67000000	usd
CY2023Q4	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	67000000	usd
CY2024Q2	nxpi	Insurance Reimbursement Of Claims Potential Maximum Exposure InsuranceReimbursementOfClaimsPotentialMaximumExposure	70000000	usd
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001413447-24-000072-index-headers.html	Edgar Link	pending
0001413447-24-000072-index.html	Edgar Link	pending
0001413447-24-000072.txt	Edgar Link	pending
0001413447-24-000072-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nxpi-20240630.htm	Edgar Link	pending
nxpi-20240630.xsd	Edgar Link	pending
nxpi-20240630_g1.jpg	Edgar Link	pending
nxpi-20240630_g10.jpg	Edgar Link	pending
nxpi-20240630_g2.jpg	Edgar Link	pending
nxpi-20240630_g3.jpg	Edgar Link	pending
nxpi-20240630_g4.jpg	Edgar Link	pending
nxpi-20240630_g5.jpg	Edgar Link	pending
nxpi-20240630_g6.jpg	Edgar Link	pending
nxpi-20240630_g7.jpg	Edgar Link	pending
nxpi-20240630_def.xml	Edgar Link	unprocessable
nxpi-20240630_g8.jpg	Edgar Link	pending
nxpi-20240630_g9.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
nxpi-20240630_pre.xml	Edgar Link	unprocessable
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
nxpi-20240630_cal.xml	Edgar Link	unprocessable
nxpi-20240630_htm.xml	Edgar Link	completed
nxpi-20240630_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NXPI
NXP Semiconductors NV Stock $nxpi

2024 Q3 Form 10-Q Financial Statement

#000141344724000072 Filed on July 23, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NXPI NXP Semiconductors NV Stock $nxpi

2024 Q3 Form 10-Q Financial Statement

#000141344724000072 Filed on July 23, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NXPI
NXP Semiconductors NV Stock $nxpi